Publisher
Proceedings of the National Academy of Sciences
Reference19 articles.
1. From target discovery to clinical drug development with human genetics
2. Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart Disease
3. M. O'Riordan How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts. TCTMD (2017). https://www.tctmd.com/news/how-low-can-you-go-concerns-over-aggressive-ldl-lowering-eased-pcsk9-evidence-mounts. Accessed 28 August 2023.
4. Lipid-Lowering Therapy and Hemorrhagic Stroke Risk
5. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia